

Indication:
KESIMPTA® is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features¹
Reference:
IE224173 July 2022
Indication:
KESIMPTA® is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features¹